5-(7-cyclopropylpyrazolo[1,5-a]pyrimidin-5-yl)-1H-pyrimidine-2,4-dione;1-(2,2,2-trifluoroethyl)indazole
C22H18F3N7O2 — CID 157034354
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(7-cyclopropylpyrazolo[1,5-a]pyrimidin-5-yl)-1H-pyrimidine-2,4-dione;1-(2,2,2-trifluoroethyl)indazole
5-(7-cyclopropylpyrazolo[1,5-a]pyrimidin-5-yl)-1H-pyrimidine-2,4-dione;1-(2,2,2-trifluoroethyl)indazole (PubChem CID 157034354) has the molecular formula C22H18F3N7O2 and a molecular weight of 469.43 g/mol. Its IUPAC name is 5-(7-cyclopropylpyrazolo[1,5-a]pyrimidin-5-yl)-1H-pyrimidine-2,4-dione;1-(2,2,2-trifluoroethyl)indazole.
Molecular Properties
| Compound Name | 5-(7-cyclopropylpyrazolo[1,5-a]pyrimidin-5-yl)-1H-pyrimidine-2,4-dione;1-(2,2,2-trifluoroethyl)indazole |
|---|---|
| PubChem CID | 157034354 |
| Molecular Formula | C22H18F3N7O2 |
| Molecular Weight | 469.43 g/mol |
| Exact Mass | 469.15 |
| IUPAC Name | 5-(7-cyclopropylpyrazolo[1,5-a]pyrimidin-5-yl)-1H-pyrimidine-2,4-dione;1-(2,2,2-trifluoroethyl)indazole |
| SMILES | FC(F)(F)Cn1ncc2ccccc21.O=c1[nH]cc(-c2cc(C3CC3)n3nccc3n2)c(=O)[nH]1 |
| InChI | InChI=1S/C13H11N5O2.C9H7F3N2/c19-12-8(6-14-13(20)17-12)9-5-10(7-1-2-7)18-11(16-9)3-4-15-18;10-9(11,12)6-14-8-4-2-1-3-7(8)5-13-14/h3-7H,1-2H2,(H2,14,17,19,20);1-5H,6H2 |
| InChIKey | BQJCCWGLVHSJGK-UHFFFAOYSA-N |
| XLogP | 3.25 |
| TPSA | 113.73 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.43 |
| LogP ≤ 5 | 3.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157034354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.